In addition, reinforcement learning algorithms, such as Q-learning, have been utilized to provide personalized insulin doses for type 1 diabetic patients based on real-time CGM device measurements and patient-specific parameters, including exercise and alcohol intake [37]. This evidence concerns the gene INS and type 1 diabetes mellitus.